Stephen Whitehead, CEO, ABPI, comments:
"We were delighted to see Sir Andrew Witty receive a Knighthood for his pioneering leadership in one of the UK’s most successful companies; Dr Richard Barker OBE acknowledged for his work on behalf of the research-based pharmaceutical industry; and Dr John Stageman OBE rewarded for his services to the Biotechnology Industry and the whole life sciences sector.
"At this challenging time, encouragement for our industry is very welcome as we seek to play a dynamic role in the future recovery of the UK economy.”
ABPI Press Office
Tel: +44 (0) 20 7747 1410 or +44 (0) 20 7747 1441
Mobile: +44 (0) 7850 312064 or +44 (0) 7808 641811
Notes to editors
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. Our members supply 90 per cent of all medicines used by the NHS, and are researching and developing 90 per cent of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
We are the Government recognised body negotiating the pricing of branded medicines on behalf of the entire industry. Working with our Research Affiliate Members, we promote the UK as a destination of choice for international life sciences investment.